Fuping Chen - Aug 23, 2023 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Role
Executive Vice President, Sales-China of ACM Research (Shanghai), Inc., a subsidiary of the Issuer
Signature
/s/ Mark McKechnie, Attorney-in-Fact for Fuping Chen
Stock symbol
ACMR
Transactions as of
Aug 23, 2023
Transactions value $
-$1,463,197
Form type
4
Date filed
8/25/2023, 05:46 PM
Previous filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $96.2K +96.2K $1.00* 96.2K Aug 23, 2023 Direct
transaction ACMR Class A Common Stock Options Exercise $15.6K +8.84K +9.19% $1.77* 105K Aug 23, 2023 Direct
transaction ACMR Class A Common Stock Sale -$1.58M -105K -100% $15.00 0 Aug 23, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -46.2K -100% $0.00* 0 Aug 23, 2023 Class A Common Stock 46.2K $1.00 Direct F3
transaction ACMR Stock Option Options Exercise $0 -50K -100% $0.00* 0 Aug 23, 2023 Class A Common Stock 50K $1.00 Direct F3
transaction ACMR Stock Option Options Exercise $0 -8.84K -5.89% $0.00 141K Aug 23, 2023 Class A Common Stock 8.84K $1.77 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The option was fully vested and exercisable.

Remarks:

Executive Vice President, Sales-China of ACM Research (Shanghai), Inc., a subsidiary of the Issuer